Life Briefing: Pharma Delays Launches in Europe Amid U.S. Pressure Strategic angle: Drugmakers are postponing the release of new medicines in Europe due to shifting pricing policies and pressures from the U.S. Editorial Staff Mar 31
Life Briefing: A new survey examines mental health outcomes of gender euphoria Strategic angle: Lead exposure and heart disease, promoting psychedelics on YouTube, and other health news from Morning Rounds Editorial Staff Mar 31
Life Briefing: Psychedelic Biotechs Under Scrutiny for YouTube Promotions Strategic angle: Biogen and Eli Lilly make takeover moves, while Doctors Without Borders criticizes Gilead amidst growing concerns in the biotech sector. Editorial Staff Mar 31
Life Briefing: Whoop, maker of health and fitness tracking wristbands, valued at $10 billion after latest fundraising Strategic angle: Whoop raised $575 million from investors including the Mayo Clinic and the sovereign wealth fund of Qatar. Editorial Staff Mar 31
Life Briefing: Public Opinion on Prescription Drugs and Their Prices Strategic angle: An in-depth look at the public's attitudes toward prescription drugs and their prices based on recent KFF poll findings. Editorial Staff Mar 31
Life Briefing: Biogen to acquire immunology biotech Apellis for $5.6 billion Strategic angle: Biogen is buying Apellis Pharmaceuticals for $5.6 billion upfront as it looks to expand its immunology business. Editorial Staff Mar 31
Life Briefing: Biotech VCs Move Upstream in China's Scientific Pipelines Strategic angle: U.S. venture capital firms are proactively investing in Chinese biotech, shifting their strategy as competition intensifies. Editorial Staff Mar 31
Life Briefing: Opinion: How the next CDC director can win back America’s trust Strategic angle: “The CDC stands at an inflection point,” write Charles J. Lockwood, Robert C. Gallo, and Sten H. Vermund. Editorial Staff Mar 31
Life Briefing: Pharma giant Takeda to lay off nearly 250 workers in latest job cutting Strategic angle: Takeda Pharmaceuticals, the largest biopharma employer in Mass., will lay off 250 workers in Cambridge beginning in July. Editorial Staff Mar 30
Life Briefing: Doctors Without Borders calls Gilead ‘unconscionable’ for refusing to sell HIV prevention drug Strategic angle: The organization criticized Gilead Sciences after months of negotiations for a limited supply of lenacapavir. Editorial Staff Mar 30
Life Briefing: Why this Stanford psychiatrist thinks diet can influence serious mental health disorders Strategic angle: Shebani Sethi is at the vanguard of metabolic psychiatry, a field that investigates the link between diet and serious mental health disorders. Editorial Staff Mar 30
Life Briefing: Tracking Implementation of the 2025 Reconciliation Law: Medicaid Work Requirements Data and Policies Strategic angle: Detailed state and national data related to the 2025 Reconciliation Law Medicaid Work Requirements Editorial Staff Mar 30
Life Briefing: Early signs of Alzheimer’s often go undetected. These researchers want to change that Strategic angle: Using AI to analyze changes in brain scans can predict Alzheimer’s with nearly 93 percent accuracy, scientists say. Editorial Staff Mar 30
Life Briefing: Lead still raises risk of heart disease, years after exposure, study warns Strategic angle: A JAMA study details how lead lingers in the body and how it can elevate blood pressure, harm blood vessel lining, and raise risk of heart attack. Editorial Staff Mar 30
Life Briefing: The omnipresent power of health care jobs Strategic angle: The American workforce has grown in large part thanks to the health care industry, but one key sector is cutting back. Editorial Staff Mar 30
Life Briefing: Biogen Lupus Drug Shows Promise in Mid-Stage Study Strategic angle: The drug demonstrates improved skin clearance, marking a significant advancement in lupus treatment. Editorial Staff Mar 30
Life Briefing: Raw dairy co. refutes connection to E. coli outbreak Strategic angle: The next CDC director role, health care giants trimming jobs, and more news from Morning Rounds Editorial Staff Mar 30
Life Briefing: Trump Pushes Drug Pricing Policy Amid Biotech Developments Strategic angle: The White House shares legislative text on drug pricing with major pharmaceutical companies. Editorial Staff Mar 30
Life Briefing: 7 Big Challenges for the Next CDC Director Strategic angle: Whoever takes over the CDC next will face immediate and enormous challenges. Here are a few. Editorial Staff Mar 30
Life Briefing: Health care jobs growth is stagnating at the biggest for-profit firms Strategic angle: Major health insurers are trimming jobs, and Medicaid cuts could soon force hospitals to lay off workers. Editorial Staff Mar 30